登录 注册 会员服务 联系我们

Safety of the PD-1 antibody pembrolizumab in patients with high-grade adverse events under ipilimumab treatment

  • Published:2016-07 Issue:7 Volume:27 Page:1353-1354
  • ISSN:0923-7534
  • Container-title:Annals of Oncology
  • language:en
  • Short-container-title:Annals of Oncology

Author:

Bender C.,Dimitrakopoulou-Strauss A.,Enk A.,Hassel J.C.

Funder

MSD

Merck Sharp & Dohme

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference5 articles.

1. Freie Vorträge;Bender;JDDG: Journal der Deutschen Dermatologischen Gesellschaft,2015

2. Safety of pembrolizumab (pem) in patients (pts) who stopped ipilimumab (ipi) due to immune-related adverse events;Shoushtari;ASCO Meet Abstr,2015

3. Survival, biomarker, and toxicity analysis of nivolumab (NIVO) in patients that progressed on ipilimumab (IPI);Weber;ASCO Meet Abstr,2015

4. Common Terminology Criteria for Adverse Events v4.0;National Cancer Institute,2009

5. Ipilimumab therapy in patients with advanced melanoma and preexisting autoimmune disorders;Johnson;JAMA Oncol,2015

Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Eventos adversos reumatológicos secundarios al uso de inhibidores de punto de control inmunitario;Reumatología Clínica;2023-04

2. Rheumatological adverse events secondary to immune checkpoint inhibitors;Reumatología Clínica (English Edition);2023-04

3. Miscellaneous Rheumatic Syndromes;Rheumatic Diseases and Syndromes Induced by Cancer Immunotherapy;2021

4. Rheumatic Manifestations in Patients Treated with Immune Checkpoint Inhibitors;International Journal of Molecular Sciences;2020-05-11

5. Systemic Vasculitis Associated With Immune Check Point Inhibition: Analysis and Review;Current Rheumatology Reports;2019-05-21
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3